Behavioral pharmacology of N-Methyl-D-aspartate antagonists: Implications for the study and pharmacotherapy of anxiety and schizophrenia

Experimental and Clinical Psychopharmacology

Volumn 5, Issue 4, 1997, Pages 365-374

  Wiley, Jenny L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 5 CHLORO 7 TRIFLUOROMETHYL 2,3 QUINOXALINEDIONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ANXIOLYTIC AGENT; CLOZAPINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; ELIPRODIL; HALOPERIDOL; IFENPRODIL; MAGNESIUM; MDL 100458; MDL 102288; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANXIETY; ANXIETY NEUROSIS; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; HUMAN; NONHUMAN; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; N-METHYLASPARTATE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0030693348     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.5.4.365     Document Type: Review

References (123)

1. Amalric, M., Ouagazzal A., Baunez, C., & Nieoullon, A. (1994). Functional interactions between glutamate and dopamine in the rat striatum. Neurochemistry International, 25, 123-131.
2. Angrist, B., & Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis: Preliminary observations. Biological Psychiatry, 2, 95-107.
3. Anthony, E. W., & Nevins, M. E. (1993). Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. European Journal of Pharmacology, 250, 317-324.
4. Bakshi, V. P., & Geyer, M. A. (1995). Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology, 122, 198-201.
5. Bakshi, V. P., Swerdlow, N. R., & Geyer, M. A. (1994). Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. Journal of Pharmacology and Experimental Therapeutics, 271, 787-794.
6. Balster, R. L. (1989). Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline. Journal of Pharmacology and Experimental Therapeutics, 249, 749-756.
7. Balster, R. L. (1990). Perception of drug effects. In M. A. Berkley & W. C. Stebbins (Eds.), Comparative perception (pp. 127-154). New York: Wiley.
8. Balster, R. L., & Chait, L. D. (1978). The effects of phencyclidine on amphetamine stereotypy in rats. European Journal of Pharmacology, 48, 445-450.
9. Balster, R. L., Mansbach, R. S., Shelton, K. L., Nicholson, K. L., Grech, D. M., Wiley, J. L., Li, H., & Weber, E. (1995). Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behavioural Pharmacology, 6, 577-589.
10. Balster, R. L., Nicholson, K. L., & Sanger, D. J. (1994). Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug & Alcohol Dependence, 35, 211-216.
11. Balster, R. L., & Wessinger, W. D. (1983). Central nervous system depressant effects of phencyclidine. In J. M. Kamenka, E. F. Domino, & P. Geneste (Eds.), Phencyclidine and related arylcyclohexylamines: Present and future applications (pp. 291-309). Ann Arbor, MI: NPP Books.
12. Baron, S. P., & Moerschbaecher, J. M. (1996). Disruption of learning by excitatory amino acid receptor antagonists. Behavioural Pharmacology, 6, 573-584.
13. Baron, S. P., & Woods, J. H. (1995). Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology, 118, 42-51.
14. Beardsley, P. M., & Balster, R. L. (1988). Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine. Journal of Pharmacology and Experimental Therapeutics, 244, 34-40.
15. Bennett, D. A., & Amrick, C. L. (1987). Antagonists at the N-methyl-D-aspartate receptor produce anticonflict effects. In T. P. Hicks, D. Lodge, & H. McLennan (Eds.), Excitatory amino acid neurotransmission (pp. 213-216). New York: Alan R. Liss.
16. Bobelis, D. J., & Balster, R. L. (1993). Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 264, 845-853.
17. Brady, K. T., & Balster, R. L. (1981). Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey. Pharmacology Biochemistry and Behavior, 14, 213-218.
18. Brady, K. T., & Balster, R. L. (1982). Discriminative stimulus properties of stereoisomers of cyclazocine in phencyclidine-trained squirrel monkeys. Life Sciences, 31, 541-549.
19. Brady, K. T., Balster, R. L., & May, E. L. (1982). Stereoisomers of N-allylnormetazocine: Phencyclidine-like behavioral effects in squirrel monkeys and rats. Science, 215, 178-180.
20. Braff, D. L., Stone, C., Callaway, E., Geyer, M. A., Click, I. D., & Bali, L. (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology, 15, 339-343.
21. Bristow, L. J., Landon, L., Saywell, K. L., & Tricklebank, M. D. (1995). The glycine/NMDA receptor antagonist L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat. Psychopharmacology, 118, 230-232.
22. Browne, R. (1986). Discriminative stimulus properties of PCP mimetics. In D. H. Clouet (Ed.), Phencyclidine: An update (pp. 134-147). Rockville, MD: National Institute on Drug Abuse.
23. Callahan, P. M., Appel, J. B., & Cunningham, K. A. (1991). Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology, 103, 50-55.
24. Carlezon, W. A., Jr., & Wise, R. A. (1996). Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. Journal of Neuroscience, 16, 3112-3122.
25. Carlsson, M., & Carlsson, A. (1989a). Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. Journal of Neural Transmission, 77, 65-71.
26. Carlsson, M., & Carlsson, A. (1989b). The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Journal of Neural Transmission, 75, 221-226.
27. Carlsson, M., & Carlsson, A. (1990). Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends in Neurosciences, 13, 272-276.
28. Castellani, S., & Adams, P. M. (1981a). Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. European Journal of Pharmacology, 73, 143-154.
29. Castellani, S., & Adams, P. M. (1981b). Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat. Neuropharmacology, 20, 371-374.
30. Corbett, R. (1995). Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue. Pharmacology Biochemistry and Behavior, 51, 561-564.
31. Corbett, R., Camacho, F., Woods, A. T., Kerman, L. L., Fishkin, R. J., Brooks, K., & Dunn, R. W. (1995). Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology, 120, 67-74.
32. Corbett, R., & Dunn, R. W. (1993). Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuropharmacology, 32, 461-466.
33. Criswell, H. E., Knapp, D. J., Overstreet, D. H., & Breese, G. R. (1994). Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity. Alcoholism: Clinical and Experimental Research, 18, 596-601.
34. Deutsch, S. I., Rosse, R. B., Paul, S. M., Tomasino, V., Koetzner, L., Morn, C. B., & Mastropaolo, J. (1996). 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology, 15, 37-43.
35. Ellenbroek, B. A., & Cools, A. R. (1990). Animal models with construct validity for schizophrenia. Behavioural Pharmacology, 1, 469-490.
36. Ellinwood, E. H., Jr., & Kilbey, M. M. (1977). Chronic stimulant intoxication models of psychosis. In I. Hanin & E. Usdin (Eds.), Animal models in psychiatry and neurology (pp. 61-74). Oxford: Pergamon Press.
37. Erard, R., Luisada, P. V., & Peele, R. (1980). The PCP psychosis: Prolonged intoxication or drug-precipitated functional illness? Journal of Psychedelic Drugs, 12, 235-251.
38. Evans, S. M., & Johanson, C. E. (1987). Amphetamine-like effects of anorectics and related compounds in pigeons. Journal of Pharmacology and Experimental Therapeutics, 241, 817-825.
39. Faiman, C. P., Viu, E., Skolnick, P., & Trullas, R. (1994). Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure. Journal of Pharmacology and Experimental Therapeutics, 270, 528-533.
40. France, C. P., Moerschbaecher, J. M., & Woods, J. H. (1991). MK-801 and related compounds in monkeys: Discriminative stimulus effects and effects on a conditional discrimination. Journal of Pharmacology and Experimental Therapeutics, 257, 727-734.
41. France, C. P., Woods, J. H., & Ornstein, P. (1989). The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. European Journal of Pharmacology, 159, 133-139.
42. French, D., & Witkin, J. M. (1993). Effects of the dopamine release inhibitor, CGS 10746B, on the locomotor stimulant and discriminative stimulus effects of cocaine and methamphetamine. Pharmacology Biochemistry and Behavior, 46, 989-993.
43. Galloway, M. P. (1988). Neurochemical interactions of cocaine with dopaminergic systems. Trends in Pharmacological Sciences, 9, 451-454.
44. Ginski, M. J., & Witkin, J. M. (1994). Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology, 114, 573-582.
45. Gold, L. H., & Balster, R. L. (1993). Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline. European Journal of Pharmacology, 230, 285-292.
46. Hertel, P., Mathe, J. M., Nomikos, G. G., Iurlo, M., Mathe, A. A., & Svensson, T. H. (1996). Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behavioural Brain Research, 72, 103-114.
47. Hoffman, D. C. (1992). Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. Journal of Neural Transmission (General Section), 89, 1-10.
48. Hoffman, D. C., Donovan, H., & Cassella, J. V. (1993). The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology, 111, 339-344.
49. Huffman, H. S., & Ison, J. R. (1980). Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychological Review, 87, 175-189.
50. Holtzman, S. G. (1980). Phencyclidine-like discriminative effects of opioids in the rat. Journal of Pharmacology and Experimental Therapeutics, 214, 614-619.
51. Irifune, M., Shimizu, T., Nomoto, M., & Fukuda, T. (1995). Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacology Biochemistry and Behavior, 51, 291-296.
52. Jackson, D. M., Johansson, C., Lindgren, L. M., & Bengtsson, A. (1994). Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology Biochemistry and Behavior, 48, 465-471.
53. Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148, 1301-1308.
54. Jewett, D. C., Butelman, E. R., & Woods, J. H. (1996). Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Research, 715, 25-31.
55. Johansson, C., Jackson, D. M., & Svensson, L. (1994). The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology, 116, 437-442.
56. Johnson, K. M., & Jones, S. M. (1990). Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Annual Review of Pharmacology and Toxicology, 30, 707-750.
57. Jortani, S. A., Willetts, J., & Balster, R. L. (1992). Systemic magnesium chloride administration fails to produce phencyclidine-like discriminative stimulus effects in rats. Neuroscience Letters, 135, 136-138.
58. Kehne, J. H., Baron, B. M., Harrison, B. L., McCloskey, T. C., Palfreyman, M. G., Poirot, M., Salituro, F. G., Siegel, B. W., Slone, A. L., Van Giersbergen, P. L. M., & White, H. S. (1995). MDL 100,458 and MDL 102,288: Two potent and selective glycine receptor antagonists with different functional profiles. European Journal of Pharmacology, 284, 109-118.
59. Keith, V. A., Mansbach, R. S., & Geyer, M. A. (1991). Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of acoustic startle. Biological Psychiatry, 30, 557-566.
60. Koek, W., Woods, J. H., & Colpaert, F. C. (1990). N-Methyl-D-aspartate antagonism and phencyclidine-like activity: A drug discrimination analysis. Journal of Pharmacology and Experimental Therapeutics, 253, 1017-1025.
61. Koek, W., Woods, J. H., Jacobson, A. E., & Rice, K. C. (1987). Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: Generality across different training doses of PCP. Psychopharmacology, 93, 437-442.
62. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers, M. B., Jr., & Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Archives of General Psychiatry, 51, 199-214.
63. Lahti, A. C., Koffel, B., LaPorte, D., & Tamminga, C. A. (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, 13, 9-19.
64. Lodge, D., & Johnson, K. M. (1990). Noncompetitive excitatory amino acid receptor antagonists. Trends in Pharmacological Sciences, 11, 81-86.
65. Majeed, N. H., Przewlocka, B., Machelska, H., & Przewlocki, R. (1994). Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology, 33, 189-192.
66. Mansbach, R. S. (1991). Effects of NMDA receptor ligands on sensorimotor gating in the rat. European Journal of Pharmacology, 202, 61-66.
67. Mansbach, R. S., & Balster, R. L. (1991). Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacology Biochemistry and Behavior, 39, 971-975.
68. Mansbach, R. S., & Geyer, M. A. (1989). Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology, 2, 299-308.
69. Mansbach, R. S., & Geyer, M. A. (1991). Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine. Psychopharmacology, 105, 162-168.
70. Mansbach, R. S., Geyer, M. A., & Braff, D. L. (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology, 94, 507-514.
71. Mansbach, R. S., Willetts, J., Jortani, S. A., & Balster, R. L. (1991). NMDA antagonists: Lack of antipunishment effects in squirrel monkeys. Pharmacology Biochemistry and Behavior, 39, 977-981.
72. McMillan, D. E., & Wessinger, W. D. (1989). Interaction of the discriminative stimulus effects of phencyclidine with those of (+)-N-allylnormetazocine, pentobarbital and d-amphetamine. Pharmacology Biochemistry and Behavior, 32, 711-715.
73. McMillan, D. E., Wessinger, W. D., Paule, M. G., & Wenger, G. R. (1989). A comparison of interoceptive and exteroceptive discrimination in the pigeon. Pharmacology Biochemistry and Behavior, 34, 641-647.
74. McQuade, R. D., Duffy, R. A., Coffin, V. L., & Barnett, A. (1992). In vivo binding to dopamine receptors: A correlate of potential antipsychotic activity. European Journal of Pharmacology, 215, 29-34.
75. Moghaddam, R. (1994). Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 18, 859-870.
76. Monaghan, D. T., & Cotman, C. W. (1989). Regional variations in NMDA receptor properties. In J. C. Watkins & G. L. Collingridge (Eds.), The NMDA receptor (pp. 53-64). Oxford: Oxford University Press.
77. Montague, P. R., Gancayco, C. D., Winn, M. J., Marchase, R. B., & Friedlander, M. J. (1994). Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science, 263, 973-977.
78. Niemegeers, C. J. E., & Janssen, P. A. J. (1979). A systematic study of the pharmacological activity of dopamine antagonists. Life Sciences, 24, 2201-2216.
79. Poling, A., Cleary, J., Jackson, K., & Wallace, S. (1981). d-Amphetamine and phencyclidine alone and in combination: Effects on fixed-ratio and interresponse-time-greater-than-t responding in rats. Pharmacology Biochemistry and Behavior, 15, 357-361.
80. Pontecorvo, M. J., Clissold, D. B., White, M. F., & Ferkany, J. W. (1991). N-methyl-D-aspartate antagonists and working memory performance: Comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. Behavioral Neuroscience, 105, 521-535.
81. Przegalinski, E., Tatarczynska, E., Deren-Wesolek, A., & Chojnacka-Wojcik, E. (1996). Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. Pharmacology Biochemistry and Behavior, 54, 73-77.
82. Rao, T. S., Kim, H. C., Lehmann, J., Martin, L. L., & Wood, P. L. (1990). Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: Tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology, 29, 225-230.
83. Rupniak, N. M. J., Boyce, S., Tye, S., Cook, G., & Iversen, S. D. (1993). Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates. Pharmacology Biochemistry and Behavior, 44, 153-156.
84. Sams-Dodd, F. (1996). Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia. Behavioural Pharmacology, 7, 3-23.
85. Sawaguchi, T., & Goldman-Rakic, P. S. (1994). Role of D1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. Journal of Neurophysiology, 71, 515-528.
86. Schoepp, D. D., & Johnson, B. G. (1989). Comparison of excitatory amino acid-stimulated phosphoinositide hydrolysis and N-3H acetylaspartylglutamate binding in rat brain: Selective inhibition of phosphoinositide hydrolysis by 2-amino-3-phosphonopropionate. Journal of Neurochemistry, 53, 273-278.
87. Seeman, P. (1992). Receptor selectivities of atypical neuroleptics. In H. Y. Meltzer (Ed.), Novel antipsychotic drugs (pp. 145-154). New York: Raven Press.
88. Shannon, H. E. (1981). Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. Journal of Pharmacology and Experimental Therapeutics, 216, 543-551.
89. Singh, L., Menzies, R., & Tricklebank, M. D. (1990). The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. European Journal of Pharmacology, 186, 129-132.
90. Sladeczek, F., Recasens, M., & Bockaert, J. (1988). A new mechanism for glutamate receptor action: Phosphoinositide hydrolysis. Trends in Neurosciences, 11, 545-549.
91. Slifer, B. L., & Balster, R. L. (1988). Phencyclidine-like discriminative stimulus effects of the stereoisomers of alpha- and betacyclazocine in rats. Journal of Pharmacology and Experimental Therapeutics, 244, 606-612.
92. Soderpalm, A. K., Blomqvist, O., Engel, J. A., & Soderpalm, B. (1995). Characterization of the anticonflict effect of MK-801, a non-competitive NMDA antagonist. Pharmacology and Toxicology, 76, 122-127.
93. Solomon, R. E., Herling, S., Domino, E. F., & Woods, J. H. (1982). Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys. Neuropharmacology, 21, 1329-1336.
94. Steinpreis, R. E., & Salamone, J. D. (1993). The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: A microdialysis and behavioral study. Brain Research, 612, 263-270.
95. Stewart, J., Deschamps, S. E., & Amir, S. (1994). Inhibition of nitric oxide synthase does not block development of sensitization to the behavioral activating effects of amphetamine. Brain Research, 641, 141-144.
96. Swerdlow, N. R., & Geyer, M. A. (1993). Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacology Biochemistry and Behavior, 44, 741-744.
97. Swerdlow, N. R., Keith, V. A., Braff, D. L., & Geyer, M. A. (1991). Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. Journal of Pharmacology and Experimental Therapeutics, 256, 530-536.
98. Swerdlow, N. R., Zisook, D., & Taaid, N. (1994). Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine. Psychopharmacology, 114, 675-678.
99. Vasar, E., Harro, J., Lang, A., Soosaar, A., Oopik, T., Koks, S., Sihver, S., & Volke, V. (1993). Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze: Involvement of NMDA and CKK receptors. European Neuropsychopharmacology, 3, 63-73.
100. Verma, A., & Kulkarni, S. K. (1992). Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology, 107,431-436.
101. Verma, A., & Moghaddam, B. (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. Journal of Neuroscience, 16, 373-379.
102. Volke, V., Koks, S., Vasar, E., Bourin, M., Bradwejn, J., & Mannisto, P. T. (1995). Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport,6, 1285-1288.
103. Watkins, J. C. (1989). The NMDA receptor concept: Origins and development. In J. C. Watkins & G. L. Collingridge (Eds.), The NMDA receptor (pp. 1-17). Oxford: Oxford University Press.
104. Wedzony, K., Golembiowska, K., & Zazula, M. (1994). Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 350, 555-562.
105. Wiley, J. L. (1994). Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response. Pharmacology Biochemistry and Behavior, 49, 1025-1028.
106. Wiley, J. L. (1995). Effect of repeated haloperidol administration on phencyclidine discrimination in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 19, 699-711.
107. Wiley, J. L., & Balster, R. L. (1992). Preclinical evaluation of N-methyl-D-aspartate antagonists for antianxiety effects: A review. In J. M. Kamenka & E. F. Domino (Eds.), Multiple sigma and PCP receptor ligands: Mechanisms for neuromodulation and neuroprotection? (pp. 801-815). Ann Arbor, MI: NPP Books.
108. Wiley, J. L., & Balster, R. L. (1993). NMDA antagonists: A novel class of anxiolytics? In M. Hamon, H. Oilat, & M.-H. Thiébot (Eds.), Anxiety: Neurobiological, clinical, and therapeutic aspects (pp. 177-184). Montrouge, France: John Libbey Eurotext.
109. Wiley, J. L., & Balster, R. L. (1994). Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle. Psychopharmacology, 116, 266-272.
110. Wiley, J. L., Cristello, A. F., & Balster, R. L. (1995). Effects of site-selective NMDA antagonists in an elevated plus-maze model of anxiety in mice. European Journal of Pharmacology, 294, 101-107.
111. Wiley, J. L., Golden, K. M., & Bowen, S. E. (1997). Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats. European Journal of Pharmacology, 328, 125-130.
112. Wiley, J. L., Li, H., & Balster, R. L. (in press). Discriminative stimulus effects of site-selective N-methyl-D-aspartate antagonists in NPC 17742-trained rats and squirrel monkeys. Psychopharmacology.
113. Willetts, J., & Balster, R. L. (1988a). Phencyclidine-like discriminative stimulus properties of MK-801 in rats. European Journal of Pharmacology, 146, 167-169.
114. Willetts, J., & Balster, R. L. (1988b). The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidinetrained rats. Neuropharmacology, 27, 1249-1256.
115. Willetts, J., Balster, R. L., & Leander, J. D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences, 11, 423-428.
116. Willetts, J., Bobelis, D. J., & Balster, R. L. (1989). Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626. Psychopharmacology, 99, 458-462.
117. Willetts, J., Clissold, D. B., Hartman, T. L., Brandsgaard, R. R., Hamilton, G. S., & Ferkany, J. W. (1993). Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. Journal of Pharmacology and Experimental Therapeutics, 265, 1055-1062.
118. Willetts, J., Rice, A., & Balster, R. L. (1989). (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists. Behavioural Pharmacology, 1, 453-458.
119. Witkin, J. M., Brave, S., French, D., & Geter-Douglass, B. (1995). Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnineinsensitive modulatory site of the N-methyl-D-aspartate receptor. Journal of Pharmacology and Experimental Therapeutics, 275, 1267-1273.
120. Witkin, J. M., Steele, T. D., & Sharpe, L. G. (1997). Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Journal of Pharmacology and Experimental Therapeutics, 280, 46-52.
121. Young, A. B., & Fagg, G. E. (1990). Excitatory amino acid receptors in the brain: Membrane binding and receptor autoradiographie approaches. Trends in Pharmacological Sciences, 11, 126-133.
122. Young, A. M., & Sannerud, C. A. (1989). Tolerance to drug discriminative stimuli. In A. J. Goudie & M. W. Emmett-Oglesby (Eds.), Psychoactive drugs: Tolerance and sensitization (pp. 221-278). Clifton, NJ: Humana Press.
123. Zhang, J., Chiodo, L. A., & Freeman, A. S. (1992). Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Research, 590, 153-163.